
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. Keeping that in mind, here is one cash-producing company that leverages its financial strength to beat its competitors and two best left off your watchlist.
Two Stocks to Sell:
Vontier (VNT)
Trailing 12-Month Free Cash Flow Margin: 14.3%
A spin-off of a spin-off, Vontier (NYSE: VNT) provides electronic products and systems to the transportation, automotive, and manufacturing sectors.
Why Should You Sell VNT?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Anticipated sales growth of 1.6% for the next year implies demand will be shaky
- Performance over the past five years shows its incremental sales were less profitable as its earnings per share were flat
Vontier is trading at $35.96 per share, or 10.3x forward P/E. Dive into our free research report to see why there are better opportunities than VNT.
Charles River Laboratories (CRL)
Trailing 12-Month Free Cash Flow Margin: 12.9%
Named after the Massachusetts river where it was founded in 1947, Charles River Laboratories (NYSE: CRL) provides non-clinical drug development services, research models, and manufacturing support to pharmaceutical and biotechnology companies.
Why Does CRL Worry Us?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Projected sales for the next 12 months are flat and suggest demand will be subdued
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
At $175.00 per share, Charles River Laboratories trades at 15.5x forward P/E. If you’re considering CRL for your portfolio, see our FREE research report to learn more.
One Stock to Watch:
Helmerich & Payne (HP)
Trailing 12-Month Free Cash Flow Margin: 4.4%
Operating the largest fleet of super-spec rigs in North America with technology that can drill horizontal wells over two miles long, Helmerich & Payne (NYSE: HP) provides drilling rigs and crews to oil and gas companies that need wells drilled to extract hydrocarbons from underground.
Why Do We Watch HP?
- Impressive 25.4% annual revenue growth over the last five years indicates it’s winning market share this cycle
- $4.09 billion in revenue gives its scale, which leads to bargaining power with suppliers and retailers
- EBITDA margin improvement of 14.5 percentage points over the last five years demonstrates its ability to scale efficiently
Helmerich & Payne’s stock price of $34.60 implies a valuation ratio of 67x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.